2021 annual financial data
Rigel Pharmaceuticals 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was 3.94%.
Operating income was -12,496,000 USD and net income was -17,914,000 USD.
Operating cash flow was 5,878,000 USD.
Get free Rigel Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 149,236,000 USD
- Operating income
- -12,496,000 USD
- Net income
- -17,914,000 USD
- Operating cash flow
- 5,878,000 USD